SPDR S&P Pharmaceuticals ETF (XPH): Price and Financial Metrics ETF
XPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $38.19 | 52-week high | $44.31 |
| Prev. close | $37.61 | 52-week low | $34.67 |
| Day low | $37.47 | Volume | 24,078 |
| Day high | $38.24 | Avg. volume | 46,790 |
| 50-day MA | $37.38 | Dividend yield | 1.49% |
| 200-day MA | $40.66 |
XPH Stock Price Chart Interactive Chart >
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Pharmaceuticals Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 189.88M |
| Net Asset Value (NAV) | $37.60 |
| Options? | Yes |
| Total Holdings | 42 |
XPH Top Holdings
| Symbol | Company | % of Total |
| ITCI | INTRA CELLULAR THERAPIES INC | 5.32% |
| ELAN | ELANCO ANIMAL HEALTH INC | 5.17% |
| LLY | ELI LILLY + CO | 5.13% |
| JNJ | JOHNSON + JOHNSON | 4.9% |
| ZTS | ZOETIS INC | 4.84% |
| MRK | MERCK + CO. INC. | 4.78% |
| RPRX | ROYALTY PHARMA PLC CL A | 4.72% |
| VTRS | VIATRIS INC | 4.62% |
| PRGO | PERRIGO CO PLC | 4.57% |
| PFE | PFIZER INC | 4.53% |
XPH Price Returns
| 1-mo | 2.30% |
| 3-mo | -11.47% |
| 6-mo | -6.31% |
| 1-year | -11.21% |
| 3-year | -19.29% |
| 5-year | N/A |
| YTD | -5.93% |
| 2022 | -9.83% |
| 2021 | -10.54% |
| 2020 | 14.68% |
| 2019 | 25.61% |
| 2018 | -15.32% |
XPH Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||